Ipca Laboratories Ltd hit a fresh record high in October 2024, breaking a 2-week consolidation. Experts suggest the rally may continue, with short-term traders targeting Rs 1,650-1,680 in 1-2 months. The stock has been on an upward trend, trading above key moving averages. Traders are encouraged to buy, with a stop loss below Rs 1,450.
